Validation of the antidiabetic and hypolipidemic effects of clitocybe nuda by assessment of glucose transporter 4 and gluconeogenesis and ampk phosphorylation in streptozotocin-induced mice

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Shih, Chun Ching ^a   Chen, Mei Hsing ^b   Lin, Cheng Hsiu ^c  

^a CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b FISHERIES RESEARCH INSTITUTE   (Taiwan)

^c Ministry of Health and Welfare   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADIPOSE TRIGLYCERIDE LIPASE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CLITOCYBE NUDA EXTRACT; DIACYLGLYCEROL ACYLTRANSFERASE; DIACYLGLYCEROL ACYLTRANSFERASE 2; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 4; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LEPTIN; METFORMIN; MUSCLE PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DYSLIPIDEMIA; ENZYME PHOSPHORYLATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; MUSCLE MASS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; SKELETAL MUSCLE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; VALIDATION PROCESS; WHITE ADIPOSE TISSUE;

EID: 84896809058     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/705636     Document Type: Article

References (55)

1. Barros L., Venturini B. A., Baptista P., Estevinho L. M., Ferreira I. C. F. R., Chemical composition and biological properties of Portuguese wild mushrooms: a comprehensive study. Journal of Agricultural and Food Chemistry 2008 56 10 3856 3862 2-s2.0-45549101213 10.1021/jf8003114
2. Dulger B., Ergul C. C., Gucin F., Antimicrobial activity of the macrofungus Lepista nuda. Fitoterapia 2002 73 7-8 695 697 2-s2.0-0036915765 10.1016/S0367-326X(02)00233-2
3. Murcia M. A., Martínez-Tomé M., Jiménez A. M., Vera A. M., Honrubia M., Parras P., Antioxidant activity of edible fungi (truffles and mushrooms): losses during industrial processing. Journal of Food Protection 2002 65 10 1614 1622 2-s2.0-0036801602
4. Chen J. T., Su H. J., Huang J. W., Isolation and identification of secondary metabolites of Clitocybe nuda inhibition of zoospore germination of Phytophthora capsici. Journal of Agricultural and Food Chemistry 2012 60 30 7341 7344 10.1021/jf301570y
5. Xu D., Sheng Y., Zhou Z.-Y., Liu R., Leng Y., Liu J.-K., Sesquiterpenes from cultures of the basidiomycete Clitocybe conglobata and their 11 β -hydroxysteroid dehydrogenase inhibitory activity. Chemical and Pharmaceutical Bulletin 2009 57 4 433 435 2-s2.0-65349153624 10.1248/cpb.57.433
6. St. Jean D. J. Jr., Wang M., Fotsch C., Inhibitors of 11 β -HSD1: a potential treatment for the metabolic syndrome. Current Topics in Medicinal Chemistry 2008 8 17 1508 1523 2-s2.0-59149094004 10.2174/156802608786413528
7. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 5 1047 1053 2-s2.0-2342466734 10.2337/diacare.27.5.1047
8. Tomlinson K. C., Gardiner S. M., Hebden R. A., Bennett T., Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacological Reviews 1992 44 1 103 150 2-s2.0-0026596711
9. Yin H., Miao J., Zhang Y., Protective effect of β -casomorphin-7 on type 1 diabetes rats induced with streptozotocin. Peptides 2010 31 9 1725 1729 2-s2.0-77955655876 10.1016/j.peptides.2010.05.016
10. Elsner M., Guldbakke B., Tiedge M., Munday R., Lenzen S., Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 2000 43 12 1528 1533 2-s2.0-0034434893 10.1007/s001250051564
11. Szkudelski T., The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiological Research 2001 50 6 537 546 2-s2.0-0035691617
12. Mueckler M., Facilitative glucose transporters. European Journal of Biochemistry 1994 219 3 713 725 2-s2.0-0028152377
13. Bryant N. J., Govers R., James D. E., Regulated transport of the glucose transporter GLUT4. Nature Reviews 2002 3 4 267 277 2-s2.0-0036270751 10.1038/nrm782
14. Lee W., Ryu J., Souto R. P., Pilch P. F., Jung C. Y., Separation and partial characterization of three distinct intracellular GLUT4 compartments in rat adipocytes. Subcellular fractionation without homogenization. The Journal of Biological Chemistry 1999 274 53 37755 37762 2-s2.0-0033621328 10.1074/jbc.274.53.37755
15. Watson R. T., Pessin J. E., Intracellular organization of insulin signaling and GLUT4 translocation. Recent Progress in Hormone Research 2001 56 175 193 2-s2.0-0035787305 10.1210/rp.56.1.175
16. Sujatha S., Anand S., Sangeetha K. N., Shilpa K., Lakshmi J., Balakrishnan A., Lakshmi B. S., Biological evaluation of (3 β)-stigmast-5- en-3-ol as potent anti-diabetic agent in regulating glucose transport using in vitro model. International Journal of Diabetes Mellitus 2010 2 2 101 109 2-s2.0-77954175315 10.1016/j.ijdm.2009.12.013
17. Huang S., Czech M. P., The GLUT4 glucose transporter. Cell Metabolism 2007 5 4 237 252 2-s2.0-33947596679 10.1016/j.cmet.2007.03.006
18. Foretz M., Toleux N., Guigas B., Horman S., Beauloye C., Andreelli F., Bertrand L., Viollet B., Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases. Médecine Sciences 2006 22 4 381 388 10.1051/medsci/2006224381 2-s2.0-33645831585
19. Viollet B., Lantier L., Devin-Leclerc J., Hebrard S., Amouyal C., Mounier R., Foretz M., Andreelli F., Targeting the AMPK pathway for the treatment of type 2 diabetes. Frontiers in Bioscience 2009 14 9 3380 3400 2-s2.0-63849085094
20. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M. F., Goodyear L. J., Moller D. E., Role of AMP-activated protein kinase in mechanism of metformin action. The Journal of Clinical Investigation 2001 108 8 1167 1174 2-s2.0-0034773404 10.1172/JCI200113505
21. Stein S. C., Woods A., Jones N. A., Davison M. D., Cabling D., The regulation of AMP-activated protein kinase by phosphorylation. Biochemical Journal 2000 345 3 437 443 2-s2.0-0034141355 10.1042/0264-6021:3450437
22. Swain T., Hills W. E., The phenolic constituents of Punnus domestica. I. Quantitative analysis of phenolic constituents. Journal of the Science of Food and Agriculture 1959 10 1 63 68 10.1002/jsfa.2740100110
23. Dubois M., Gilles K. A., Hamilton J. K., Rebers P. A., Smith F., Colorimetric method for determination of sugars and related substances. Analytical Chemistry 1956 28 3 350 356 10.1021/ac60111a017 2-s2.0-33749946901
24. Shen Q. W., Jones C. S., Kalchayanand N., Zhu M. J., Du M., Effect of dietary α -lipoic acid on growth, body composition, muscle pH, and AMP-activated protein kinase phosphorylation in mice. Journal of Animal Science 2005 83 11 2611 2617 2-s2.0-33645964962
25. Raser K. J., Posner A., Wang K. K. W., Casein zymography: a method to study -calpain, m-calpain, and their inhibitory agents. Archives of Biochemistry and Biophysics 1995 319 1 211 216 2-s2.0-0029048989 10.1006/abbi.1995.1284
26. Laemmli U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227 5259 680 685 2-s2.0-0014949207 10.1038/227680a0
27. Hayashi K., Kojima R., Ito M., Strain differences in the diabetogenic activity of streptozotocin in mice. Biological and Pharmaceutical Bulletin 2006 29 6 1110 1119 2-s2.0-33744944777 10.1248/bpb.29.1110
28. Wiernsperger N. F., Kuhlmann J., Pulus W., Preclinical pharmacology of biguanides. Oral Antidiabetics 1996 119 chapter 12 Berlin, Germany Springer 305 358 10.1007/978-3-662-09127-2-12
29. Liu S.-H., Chang Y.-H., Chiang M.-T., Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats. Journal of Agricultural and Food Chemistry 2010 58 9 5795 5800 2-s2.0-77952197534 10.1021/jf100662r
30. Choi J. S., Yokozawa T., Oura H., Improvement of hyperglycemia and hyperlipemia in streptozotocin-diabetic rats by a methanolic extract of Prunus davidiana stems and its main component, prunin. Planta Medica 1991 57 3 208 211 2-s2.0-0025897408
31. Sharma S. R., Dwivedi S. K., Swarup D., Hypoglycaemic and hypolipidemic effects of Cinnamomum tamala Nees leaves. Indian Journal of Experimental Biology 1996 34 4 372 374 2-s2.0-0030009271
32. Goldstein D. E., Little R. R., Lorenz R. A., Malone J. I., Nathan D., Peterson C. M., Tests of glycemia in diabetes. Diabetes Care 2004 27 supplement 1 S91 S93 2-s2.0-0029034717 10.2337/diacare.27.2007.S91
33. Howlett J., Ashwell M., Glycemic response and health: summary of a workshop. American Journal of Clinical Nutrition 2008 87 1 212S 216S 2-s2.0-38149079798
34. Huebschmann A. G., Regensteiner J. G., Vlassara H., Reusch J. E. B., Diabetes and advanced glycoxidation end products. Diabetes Care 2006 29 6 1420 1432 2-s2.0-33746427544 10.2337/dc05-2096
35. Al-Shamaony L., Al-Khazraji S. M., Twaij H. A. A., Hypoglycaemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals. Journal of Ethnopharmacology 1994 43 3 167 171 2-s2.0-0028037942 10.1016/0378-8741(94)90038-8
36. Rajkumar L., Srinivasan N., Balasubramanian K., Govindarajulu P., Increased degradation of dermal collagen in diabetic rats. Indian Journal of Experimental Biology 1991 29 11 1081 1083 2-s2.0-0026248458
37. Chatterja M. N., Shinde R., Text Book of Medical Biochemisty 2002 5th New Delhi, India Jaypee Brothers Medical
38. Murray R. R., Granner D. K., Mayes O. A., Rodwell V. W., Gluconeogenesis and the Control of Blood Glucose 2003 Stamford, Conn, USA Appleton and Lange
39. Minokoshi Y., Kahn C. R., Kahn B. B., Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and hlucose homeostasis. The Journal of Biological Chemistry 2003 278 36 33609 33612 2-s2.0-0141446037 10.1074/jbc.R300019200
40. Joost H.-G., Bell G. I., Best J. D., Birnbaum M. J., Charron M. J., Chen Y. T., Doege H., James D. E., Lodish H. F., Moley K. H., Moley J. F., Mueckler M., Rogers S., Schürmann A., Seino S., Thorens B., Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. American Journal of Physiology 2002 282 4 E974 E976 10.1152/ajpendo.00407.2001 2-s2.0-0036087663
41. Daisy P., Balasubramanian K., Rajalakshmi M., Eliza J., Selvaraj J., Insulin mimetic impact of catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on streptozotocin-induced diabetic Wistar rats. Phytomedicine 2010 17 1 28 36 2-s2.0-70649090094 10.1016/j.phymed.2009.10.018
42. Kurukulasuriya R., Link J. T., Madar D. J., Pei Z., Rohde J. J., Richards S. J., Souers A. J., Szczepankiewicz B. G., Prospects for pharmacologic inhibition of hepatic glucose production. Current Medicinal Chemistry 2003 10 2 99 121 2-s2.0-0037247641
43. Berg J. M., Tymoczko J. L., Stryer L., Berg J. M., Tymoczko J. L., Glycolysis and glyconeogenesis. Stryer Biochemistry 2001 New York, NY, USA W. H. Freeman 425 464
44. Guignot L., Mithieux G., Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rat. American Journal of Physiology 1999 277 6 E984 E989 2-s2.0-0033400530
45. Thiebaud D., Jacot E., DeFronzo R. A., The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 1982 31 11 957 963 2-s2.0-0019935341 10.2337/diacare.31.11.957
46. Alberts P., Nilsson C., Selén G., Engblom L. O. M., Edling N. H. M., Norling S., Klingström G., Larsson C., Forsgren M., Ashkzari M., Nilsson C. E., Fiedler M., Bergqvist E., Öhman B., Björkstrand E., Abrahmsén L. B., Selective Inhibition of 11 β -hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 2003 144 11 4755 4762 2-s2.0-0242468543 10.1210/en.2003-0344
47. Giorgino F., Laviola L., Leonardini A., Pathophysiology of type 2 diabetes: rationale for different oral antidiabetic treatment strategies. Diabetes Research and Clinical Practice 2005 68 supplement 1 S22 S29 2-s2.0-20444401915 10.1016/j.diabres.2005.03.012
48. Staels B., Fruchart J.-C., Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 2005 54 8 2460 2470 2-s2.0-23644456172 10.2337/diabetes.54.8.2460
49. Kato M., Higuchi N., Enjoji M., Reduced hepatic expression of adipose tissue triglyceride lipase and CGI-58 may contribute to the development of non-alcoholic fatty liver disease in patients with insulin resistance. Scandinavian Journal of Gastroenterology 2008 43 8 1018 1019 2-s2.0-47949122678 10.1080/00365520802008140
50. Cases S., Stone S. J., Zhou P., Yen E., Tow B., Lardizabal K. D., Voelker T., Farese R. V. Jr., Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. The Journal of Biological Chemistry 2001 276 42 38870 38876 2-s2.0-0035914356 10.1074/jbc.M106219200
51. Minokoshi Y., Kim Y.-B., Peroni O. D., Fryer L. G. D., Müller C., Carling D., Kahn B. B., Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002 415 6869 339 343 2-s2.0-0037122766 10.1038/415339a
52. Bourgeois F., Alexiu A., Lemonnier D., Dietary-induced obesity: effect of dietary fats on adipose tissue cellularity in mice. British Journal of Nutrition 1983 49 1 17 26 2-s2.0-0020669748
53. Wang M.-Y., Chen L., Clark G. O., Lee Y., Stevens R. D., Ilkayeva O. R., Wenner B. R., Bain J. R., Charron M. J., Newgard C. B., Unger R. H., Leptin therapy in insulin-deficient type I diabetes. Proceedings of the National Academy of Sciences of the United States of America 2010 107 11 4813 4819 2-s2.0-77950373635 10.1073/pnas.0909422107
54. Woods Y. L., Petrie J. R., Sutherland C., Dissecting insulin signaling pathways: individualised therapeutic targets for diagnosis and treatment of insulin resistant states. Endocrine, Metabolic & Immune Disorders 2009 9 2 187 198 2-s2.0-67650281744 10.2174/187153009788452408
55. Suwa M., Egashira T., Nakano H., Sasaki H., Kumagai S., Metformin increases the PGC-1 α protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo. Journal of Applied Physiology 2006 101 6 1685 1692 2-s2.0-33845411854 10.1152/japplphysiol.00255.2006